Pharma Sessions
Pharma Sessions
Podcast Description
Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)
Podcast Insights
Content Themes
The podcast explores a wide range of topics relevant to the pharmaceutical and medical affairs landscape. Content themes include strategies for pharmaceutical launches, innovations in medical affairs, regulatory challenges, work-life integration, clinical trial diversity, and negotiation skills. Notable episode examples include discussions on the role of AI in medical affairs, achieving work-life balance in medical professions, and the importance of financial implications caused by burnout in pharma.

Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)
Dr. Paul Peter Tak, President and CEO of Candel Therapeutics, sits down with Jonathan to discuss the company's sprint from positive Phase III results to commercial launch. They explore how Candel is redefining the biotech playbook — using an externalized, dynamic model to build commercial capabilities with speed and agility, without the burden of premature fixed costs.
Topics include Candel's viral immunotherapy CAN-2409 for localized prostate cancer, the overnight financing triggered by Phase III success, the ”one team” approach to culture and external partners, and how a lean 80-person organization is delivering the output of a mid-sized pharma company.
- 0:00 — Introduction: Dr. Paul Peter Tak and Candel Therapeutics
- 1:19 — What CAN-2409 does differently for prostate cancer patients
- 3:19 — Integrating a viral immunotherapy into existing radiation workflows
- 4:48 — The day after Phase III: shifting from R&D to launch readiness
- 6:10 — Overnight financing and pressing the button with Merck Millipore
- 9:16 — Starting with the patient journey, not ”medical affairs vs. commercial”
- 12:10 — Speed without fixed costs: the advantage of externalization
- 15:51 — The ”one team” approach: culture over credentials
- 21:14 — The Halloween party: building trust through fun
- 23:21 — Six years without missing a single catalyst
- 26:06 — What success looks like after approval
- 29:07 — Leading remotely from Portugal: the hybrid model
- 33:24 — 80 people, mid-sized pharma output: freedom and accountability
- 34:41 — AI with RI: real intelligence
Pharma Sessions is hosted by Jonathan Kaskey
Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/
Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.